This document provides information about the quality control evaluation and development of aspirin tablets. It discusses the generic and chemical properties of aspirin, its mechanism of action and common uses. It also describes evaluation parameters like weight variation, friability, hardness and disintegration time for aspirin tablets. The document outlines the assay method for determining the aspirin content in tablets. Finally, it briefly mentions that drug development involves bringing a new drug to market after a lead compound is identified.
This document provides information about the quality control evaluation and development of aspirin tablets. It discusses the generic and chemical properties of aspirin, its mechanism of action and common uses. It also describes evaluation parameters like weight variation, friability, hardness and disintegration time for aspirin tablets. The document outlines the assay method for determining the aspirin content in tablets. Finally, it briefly mentions that drug development involves bringing a new drug to market after a lead compound is identified.
This document provides information about the quality control evaluation and development of aspirin tablets. It discusses the generic and chemical properties of aspirin, its mechanism of action and common uses. It also describes evaluation parameters like weight variation, friability, hardness and disintegration time for aspirin tablets. The document outlines the assay method for determining the aspirin content in tablets. Finally, it briefly mentions that drug development involves bringing a new drug to market after a lead compound is identified.
B.PHARMA 4th year R.I.T.M LUCKNOW ROLL NO:1820350065 SUBMITTED TO: Dr. YASMIN KHATOON TABLE OF CONTENT
• General introduction of aspirin
• Evaluation of aspirin tablet • Assay of aspirin • Method of development of aspirin • References GENERAL INTRODUCTION OF ASPIRIN • GENERIC NAME: Acetylsalicylic acid • Classified in british formulary as NON STEROIDAL ANTIINFLAMATORY DRUGS. • CHEMICAL FORMULA: C9H8O4 • Average molecular weight: 180.15g/mol • SYNONYMS: Acidum acetylsalicylicum, Apirina. • MOA: Inhibitis prostaglandins synthesis, by inhibiting COX-1 AND COX-2 enzymes. • IUPAC NAME: 2-(acetyloxy)benzoic acid GENERAL INTRODUCTION OF ASPIRIN • MELTING POINT: 1350C • USES: • Anti inflammatory • Anti platelets • Fever • Cardio vascular disease • Myocardial infraction • Transient ischemic attacks (TIA) EVALUATION PARAMETER OF ASPIRIN • Drug evaluation may be defined as determination of identiy, quality of drug. • WEIGHT VARIATION: MEAN= 175.7mg • FRIABILITY: 1) 2.7unit weight 2) 1.85 unit weight 3) 2.7 unit weight • HARDBNESS:3.5+3.6+3.6+3.8+8+3.9= 3.066 kg/cm2 • DISINTEGRATION ( DT TIME) 10+9+10=29/3=9.6 min • DISSOLUTION: PASSED ASSAY OF ASPIRIN
• 15g of Acetyl salicylic acid dissolve in 15ml of ethanol.
• Add 50ml of 0.5 M NaOH. • Boil for 10 minute and then cool. • Titrate excess of alkali qwith 0.5M HCL using phenol red solution as indicator • Difference between titration represents amount of NaOH required. ASSAY OF ASPIRIN GASTRO-RESISTANT TABLETS
• 20 Tablets weighed and powdered.
• powder containing 0.5g of aspirin weighed and powdered. • 30ml of 0.5M NaOH is added and boiled upto 10 minute. • Allowded for cooling and titrated with 0.5M HCL by adding phenol red indicator. METHOD OF DEVELOPMENT OF ASPIRIN
• Drug development is the
process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. REFERENCES • https://en.wikipedia.org/wiki/Drug_development • https://pubchem.ncbi.nlm.nih.gov/compound/Aspirin • Leon Lachman book of industrail pharmacy.